Funded Tech Companies
Lys Therapeutics
Headquartered in LYON, Lys Therapeutics has funding from Bpifrance, private investors and The Michael J. Fox Foundation for Parkinson's Research.
Company Overview
Company Name
Lys Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
56 rue Saint-Jean-De-Dieu
LYON, 69007
France
LYON, 69007
France
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Lys Therapeutics, first-in-class biotherapies for neurological diseases. Lys Therapeutics' main drug-candidate, LYS241, is a first-in-class monoclonal antibody displaying a groundbreaking mechanism of action counteracting these mechanisms by specifically preventing inside blood vessels the binding of tPA on NMDA receptors, without blocking the physiological function of NMDAr.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/23/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Michel Vounatsos
Chief Executive Officer
Manuel Blanc
Chief Financial Officer
Philippe Dujardin
Chief Operating Officer
Jean-Baptiste Bertrand
Chief Operating Officer
Jordan Guyon
Chief Scientific Officer
Denis Vivien
Chief Technical Officer
Werner Klinger
VP - Bus. Development
Riad Abes
Company Investors
Browse more funded tech companies:
Lyrie.ai | Lysosomal Therapeutics
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs